Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Nasopharyngeal carcinoma Chan ATAnn Oncol 2010[Oct]; 21 Suppl 7 (ä): vii308-12With the improvement in local control achieved by more precise imaging and radiotherapy, the predominant mode of failure for nasopharyngeal carcinoma is distant metastases. Concurrent cisplatin-radiotherapy with or without adjuvant chemotherapy is the standard treatment approach for stages IIB and above disease. The addition of neoadjuvant chemotherapy has been most promising, and phase III trial results are awaited. Quantitative Epstein-Barr virus (EBV) DNA can be applied clinically for disease monitoring and follow-up, and may in future be used for risk stratification strategies. Targeted therapies against epidermal growth factor receptor and angiogenesis have demonstrated activity, and immunotherapeutic approaches are being investigated.|Carcinoma[MESH]|Combined Modality Therapy[MESH]|Epstein-Barr Virus Infections/complications/diagnosis[MESH]|Herpesvirus 4, Human/isolation & purification[MESH]|Humans[MESH]|Molecular Targeted Therapy/methods[MESH]|Nasopharyngeal Carcinoma[MESH]|Nasopharyngeal Neoplasms/diagnosis/etiology/pathology/*therapy[MESH]|Neoplasm Metastasis[MESH]|Recurrence[MESH] |